-Search query
-Search result
Showing 1 - 50 of 100 items for (author: maeda & y)

EMDB-62868: 
Cryo-EM structure of the d16:1 S1P-bound S1PR3 and Gq complex
Method: single particle / : Im D, Asada H, Iwata S, Yamauchi M, Hagiwara M

EMDB-66136: 
Cryo-EM structure of the d18:1 S1P-bound S1PR3 and Gq complex
Method: single particle / : Im D, Asada H, Iwata S, Yamauchi M, Hagiwara M

PDB-9l74: 
Cryo-EM structure of the d16:1 S1P-bound S1PR3 and Gq complex
Method: single particle / : Im D, Asada H, Iwata S, Yamauchi M, Hagiwara M

PDB-9wp9: 
Cryo-EM structure of the d18:1 S1P-bound S1PR3 and Gq complex
Method: single particle / : Im D, Asada H, Iwata S, Yamauchi M, Hagiwara M

EMDB-48922: 
Endogenous Pfs230D13-14 in complex with Pfs48/45 bound to anti-Pfs48/45 Fabs RUPA-71 and RUPA-44
Method: single particle / : Hailemariam S, Heide F, Bekkering E, Ivanochko D, Yoo R, Julien JP

PDB-9n5i: 
Endogenous Pfs230D13-14 in complex with Pfs48/45 bound to anti-Pfs48/45 Fabs RUPA-71 and RUPA-44
Method: single particle / : Hailemariam S, Heide F, Bekkering E, Ivanochko D, Yoo R, Julien JP

EMDB-48921: 
Endogenous Pfs230D1-6 in complex with RUPA-97, LMIV230-01, and 2A2 Fab domains
Method: single particle / : Heide F, Yoo R, Ivanochko D, Hailemariam S, Bekkering E, Julien JP

EMDB-48924: 
Endogenous Pfs230D9-14 in complex with Pfs48/45
Method: single particle / : Heide F, Ivanochko D, Bekkering E, Yoo R, Hailemariam S, Julien JP

EMDB-48941: 
Endogenous Pfs230D7-8 in complex with 18F25
Method: single particle / : Jackman JJ, Yoo R, Ivanochko D, Hailemariam S, Bekkering E, Julien JP

PDB-9n5h: 
Endogenous Pfs230D1-6 in complex with RUPA-97, LMIV230-01, and 2A2 Fab domains
Method: single particle / : Heide F, Yoo R, Ivanochko D, Hailemariam S, Bekkering E, Julien JP

PDB-9n5k: 
Endogenous Pfs230D9-14 in complex with Pfs48/45
Method: single particle / : Heide F, Ivanochko D, Bekkering E, Yoo R, Hailemariam S, Julien JP

PDB-9n5o: 
Endogenous Pfs230D7-8 in complex with 18F25
Method: single particle / : Jackman JJ, Yoo R, Ivanochko D, Hailemariam S, Bekkering E, Julien JP

EMDB-60544: 
Cryo-EM structure of human GLUT9 bound to urate
Method: single particle / : Matsushita D, Lee Y, Nishizawa T

EMDB-60545: 
Cryo-EM structure of human GLUT9 apo state
Method: single particle / : Matsushita D, Lee Y, Nishizawa T

PDB-8zxm: 
Cryo-EM structure of human GLUT9 bound to urate
Method: single particle / : Matsushita D, Lee Y, Nishizawa T

PDB-8zxn: 
Cryo-EM structure of human GLUT9 apo state
Method: single particle / : Matsushita D, Lee Y, Nishizawa T

EMDB-46969: 
Cholinephosphotransferase in complex with diacylglycerol in nanodisc
Method: single particle / : Roberts JR, Maeda S, Ohi MD

EMDB-42496: 
Cholinephosphotransferase in complex with CDP-choline and phosphatidylcholine
Method: single particle / : Roberts JR, Maeda S, Ohi MD

EMDB-42500: 
Cholinephosphotransferase in complex with selective inhibitor chelerythrine
Method: single particle / : Roberts JR, Maeda S, Ohi MD

PDB-8urp: 
Cholinephosphotransferase in complex with CDP-choline and phosphatidylcholine
Method: single particle / : Roberts JR, Maeda S, Ohi MD

PDB-8urt: 
Cholinephosphotransferase in complex with selective inhibitor chelerythrine
Method: single particle / : Roberts JR, Maeda S, Ohi MD

EMDB-42357: 
Cholinephosphotransferase in complex with diacylglycerol
Method: single particle / : Roberts JR, Maeda S, Ohi MD

PDB-8ul9: 
Cholinephosphotransferase in complex with diacylglycerol
Method: single particle / : Roberts JR, Maeda S, Ohi MD

EMDB-34741: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-34742: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgl: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgm: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33820: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33821: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33822: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33823: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33824: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33825: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33826: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33827: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 focused on RBD and NIV-13 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33828: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33829: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33830: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh6: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh7: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-25748: 
Cryo-EM structure of ACh-bound M2R-Go signaling complex in S1 state
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

EMDB-25749: 
Cryo-EM structure of ACh-bound M2R-Go signaling complex in S2 state
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

EMDB-25751: 
Cryo-EM structure of S1 state ACh-bound M2R-Go signaling complex with a PAM
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

EMDB-25752: 
Cryo-EM structure of S2 state ACh-bound M2R-Go signaling complex with a PAM
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

PDB-7t8x: 
Cryo-EM structure of ACh-bound M2R-Go signaling complex in S1 state
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

PDB-7t90: 
Cryo-EM structure of ACh-bound M2R-Go signaling complex in S2 state
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

PDB-7t94: 
Cryo-EM structure of S1 state ACh-bound M2R-Go signaling complex with a PAM
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

PDB-7t96: 
Cryo-EM structure of S2 state ACh-bound M2R-Go signaling complex with a PAM
Method: single particle / : Xu J, Wang Q, Du Y, Kobilka BK

EMDB-25706: 
Cryo-EM structure of human SIMC1-SLF2 complex
Method: single particle / : Maeda S, Oravcova M

PDB-7t5p: 
Cryo-EM structure of human SIMC1-SLF2 complex
Method: single particle / : Maeda S, Oravcova M, Boddy MN, Otomo T
Pages:
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
